Physician profile
Andre Olivier
NPI 1558386771
$34,020.84
in general payments reported to CMS, 2019-2025
32 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $2,987 · 2021: $3,109 · 2022: $4,611 · 2023: $4,809 · 2024: $2,508 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,855 · Consulting Fee: $1,800 · Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,854.86 |
| Consulting Fee | $1,800.00 |
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11,641.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,621.16 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $2,716.16 | 2019-2025 | Watchman Flx, Watchman Access System, Cds - Mct/Cem Monitoring |
| Medtronic, INC. | $2,682.66 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Plasmablade(Tm) |
| Actelion Pharmaceuticals US, INC. | $2,440.81 | 2019-2024 | Uptravi, Opsumit, Acclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,049.53 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $883.37 | 2019-2024 | Xarelto |
| Amgen INC. | $703.81 | 2021-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $615.83 | 2019-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $347.12 | 2022-2024 | Winrevair, Verquvo |
| Edwards Lifesciences Corporation | $276.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $274.16 | 2020-2025 | |
| Astrazeneca Pharmaceuticals Lp | $256.58 | 2020-2023 | Farxiga, Andexxa, Brilinta |
| Abbott Laboratories | $255.76 | 2022-2025 | 2nd Gen Centrimag Primary Console, Assurity |
| Amarin Pharma, INC. | $178.90 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $170.55 | 2022-2024 | Amvia Edge |
| Irhythm Technologies, INC. | $154.14 | 2024 | Zio Monitor, Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $130.72 | 2024 | |
| Heartflow, INC. | $123.78 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $62.35 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $57.45 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $55.85 | 2024 | Arcalyst |
| Vital Connect, INC | $49.13 | 2023-2024 | Vitalpatch Rtm |
| Novo Nordisk INC | $48.01 | 2023-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $43.94 | 2022-2024 | |
| Scpharmaceuticals INC. | $42.41 | 2023-2024 | |
| Esperion Therapeutics, INC. | $33.31 | 2021-2023 | Nexletol |
| Shockwave Medical, INC | $28.95 | 2021 | |
| Zoll Respicardia, INC. | $26.20 | 2022 | |
| Glaxosmithkline, LLC. | $24.52 | 2024 | Trelegy Ellipta, Arexvy |
| Baxter Healthcare | $13.43 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Olivier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.